Stay updated on CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Sign up to get notified when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.

Latest updates to the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe web page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of CNTO1959 (Guselkumab) for treating generalized pustular psoriasis and erythrodermic psoriasis, while a new identifier and revision number have been added.SummaryDifference17%
Stay in the know with updates to CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CNTO1959 for Pustular/Erythrodermic Psoriasis Clinical Trial page.